Advances include improved access to prophylaxis, multiple subcutaneous drugs in development, and research looking at better ways to personalize treatment.
For years, researchers studying the bleeding disorders community have sought answers to questions about people’s experiences that only community voices...
In May 2018, more than 200 people representing scientific researchers, hemophilia patients, advocates, clinicians and the pharmaceutical industry gathered in...